CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Cumberland Pharmaceuticals Inc. v. InnoPharma Inc.

1:12-cv-00618

Overview

Case Number 1:12-cv-00618
Filing Date 2012-05-17
Status Terminated
Termination Date 2013-11-01
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

InnoPharma Inc. Operating Company

Represented By

3 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Imron T. Aly

Email: ialy@schiffhardin.com

Plaintiff

Cumberland Pharmaceuticals Inc. Operating Company

Represented By

5 Attorneys Listed

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Kristen Healey Cramer

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320
Fax: +1 (302) 777-4224

1313 North Market Street, Suite 1200

Mark J. Feldstein

Email: mark.feldstein@finnegan.com

Laura P. Masurovsky

Email: laura.masurovsky@finnegan.com

Danielle A. Duszczyszyn

Email: Danielle.duszczyszyn@finnegan.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 19 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (19): πŸ‡¨πŸ‡¦ Canada CN πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8148356
Acetylcysteine composition and uses therefor
Filed: 2005-08-24
Issued: 2012-04-03
Expired (Term Ended) +270d PTA
Expires: 2026-05-21

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+270 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

5

Granted

2

Denied

0

Pending / Review

3

Motions by Category

Motion to Dismiss (FRCP 12(b)(6)) 4 Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
MEMORANDUM ORDER re 7 MOTION to Dismiss filed by InnoPharma Inc. is GRANTED. Signed by Judge Leonard P. Stark on 11/1/13. (ntl)
Entry #15 • 2013-11-01 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPLY BRIEF re 7 MOTION to Dismiss for Failure to State a Claim filed by InnoPharma Inc.. (Phillips, John) (Entered: 07/05/2012)
Entry #13 • 2012-07-05 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
ANSWERING BRIEF in Opposition re 7 MOTION to Dismiss for Failure to State a Claim filed by Cumberland Pharmaceuticals Inc..Reply Brief due date per Local Rules ...
Entry #12 • 2012-06-25 Document →
Motion to Dismiss (FRCP 12(b)(6)) Granted
MOTION to Dismiss for Failure to State a Claim - filed by InnoPharma Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 06/08/2012)
Entry #7 • 2012-06-08 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
OPENING BRIEF in Support re 7 MOTION to Dismiss for Failure to State a Claim filed by InnoPharma Inc..Answering Brief/Response due date per Local Rules is 6/25/...
Entry #8 • 2012-06-08 Document →

Docket Entries

(18 total)
Pleading / Complaint

COMPLAINT filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1075925.) - filed by Cumberland Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dzs, ) (Entered: 05/18/2012)

Entry #1 • 2012-05-17
1
Pleading / Complaint

COMPLAINT filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1075925.) - filed by Cumberland Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dzs, ) (Entered: 05/18/2012)

Entry #1 • 2012-05-17
2
Pleading / Complaint

COMPLAINT filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1075925.) - filed by Cumberland Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dzs, ) (Entered: 05/18/2012)

Entry #1 • 2012-05-17
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dzs, ) (Entered: 05/18/2012)

Entry #2 • 2012-05-17
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/5/12. Date of Expiration of Patent: 5/21/26.Thirty Month Stay Deadline: 10/3/2014. (dzs, ) (Entered: 05/18/2012)

Entry #3 • 2012-05-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc